文献速递产科母胎医学

孕中期无症状妇女新型蛋白生物标志物组合预测早产:PPeTaL研究

Preterm birth prediction in asymptomatic women at mid-gestation using a panel of novel protein biomarkers: the Prediction of PreTerm Labor (PPeTaL) study.
PubMed 文献 · Am J Obstet Gynecol MFM · 2020-01-09

该观察性队列研究在澳大利亚墨尔本两家医院纳入孕16+0至24+0周无症状孕妇,采集宫颈阴道液用ELISA检测生物标志物,分训练队列(n=136)和验证队列(n=150)。基于7种候选生物标志物构建的多重算法在训练队列预测自发性早产的敏感度100%(95%CI 76-100%)、特异度74%(95%CI 66-81%),验证队列敏感度91%(95%CI 62-100%)、特异度78%(95%CI 70-84%)。

要点

  • 孕中期宫颈阴道液多蛋白标志物算法可区分足月与自发性早产。
  • 训练队列敏感度100%(95%CI 76-100%),特异度74%(95%CI 66-81%)。
  • 验证队列敏感度91%(95%CI 62-100%),特异度78%(95%CI 70-84%)。

核心结论

  • 基于7种候选生物标志物的多重算法在孕中期无症状妇女中显示出临床有用的早产预测诊断价值。
  • 早期识别有早产风险的无症状妇女有助于分诊至专科门诊进一步评估和给予适当预防性治疗。

研究设计与样本

  • 观察性队列研究,2017年12月至2019年2月在澳大利亚墨尔本2家产科医院分娩的孕妇。
  • 孕16+0至24+0周采集无症状妇女宫颈阴道液样本,用酶联免疫吸附试验(ELISA)定量生物标志物浓度。
  • 按分娩日期先后分配训练队列(n=136)和验证队列(n=150)。

主要发现

  • 通过高通量生物信息学搜索发现7种代表子宫宫颈重塑关键通路的候选生物标志物,并评估其体内外研究意义。
  • 训练队列中足月产124例、自发性早产12例,算法敏感度100%(95%CI 76-100%)、特异度74%(95%CI 66-81%)。
  • 验证队列中足月产139例、早产11例,算法敏感度91%(95%CI 62-100%)、特异度78%(95%CI 70-84%)。

关键数值与推荐

  • 训练队列(n=136):敏感度100%(95%CI 76-100%),特异度74%(95%CI 66-81%)。
  • 验证队列(n=150):敏感度91%(95%CI 62-100%),特异度78%(95%CI 70-84%)。

临床怎么用

  • 孕中期无症状妇女可考虑检测宫颈阴道液多蛋白标志物组合,辅助识别自发性早产高风险者。
  • 高风险妇女可转诊至专科门诊进一步评估并接受适当预防性治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate prediction of spontaneous preterm labor/preterm birth in asymptomatic women remains an elusive clinical challenge because of the multi-etiological nature of preterm birth. OBJECTIVE: The aim of this study was to develop and validate an immunoassay-based, multi-biomarker test to predict spontaneous preterm birth. MATERIALS AND METHODS: This was an observational cohort study of women delivering from December 2017 to February 2019 at 2 maternity hospitals in Melbourne, Australia. Cervicovaginal fluid samples were collected from asymptomatic women at gestational week 16+0-24+0, and biomarker concentrations were quantified by enzyme-linked immunosorbent assay. Women were assigned to a training cohort (n = 136) and a validation cohort (n = 150) based on chronological delivery dates. RESULTS: Seven candidate biomarkers representing key pathways in utero-cervical remodeling were discovered by high-throughput bioinformatic search, and their significance in both in vivo and in vitro studies was assessed. Using a combination of the biomarkers for the first 136 women allocated to the training cohort, we developed an algorithm to stratify term birth (n = 124) and spontaneous preterm birth (n = 12) samples with a sensitivity of 100% (95% confidence interval, 76-100%) and a specificity of 74% (95% confidence interval, 66-81%). The algorithm was further validated in a subsequent cohort of 150 women (n = 139 term birth and n = 11 preterm birth), achieving a sensitivity of 91% (95% confidence interval, 62-100%) and a specificity of 78% (95% confidence interval, 70-84%). CONCLUSION: We have identified a panel of biomarkers that yield clinically useful diagnostic values when combined in a multiplex algorithm. The early identification of asymptomatic women at risk for preterm birth would allow women to be triaged to specialist clinics for further assessment and appropriate preventive treatment.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Leow SM, Di Quinzio MKW, Ng ZL, et al. Preterm birth prediction in asymptomatic women at mid-gestation using a panel of novel protein biomarkers: the Prediction of PreTerm Labor (PPeTaL) study. Am J Obstet Gynecol MFM. 2020. PMID: 33345955. doi:10.1016/j.ajogmf.2019.100084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。